Brief: Biomerieux Acquires U.S. Firm Accellix For EUR 35 Mln
Jan 22 (Reuters) - Biomerieux SA BIOX.PA: ACQUIRES ACCELLIX HAS ACQUIRED ENTIRE SHARE CAPITAL OF ACCELLIX FOR A TOTAL CASH OUT OF AROUND EUR 35 MILLION Source text: ID:nNDL4jt64Q Further company coverage: BIOX.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biomerieux SA
See all newsFactbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development